The Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) and the Spanish Federation for Rare Diseases (FEDER) have launched FollowER, a project aimed at improving the transition from pediatric to adult care for people with rare diseases, by developing a proposed care model that promotes continuity of care and coordination among healthcare professionals, facilitating the transition from pediatric to adult services and preventing interruptions in care for people with rare diseases.
The transition to adulthood is a complex stage for people with rare diseases and their families. Changes in referring specialists and healthcare professionals can lead to coordination difficulties and gaps in clinical follow-up and treatment. Therefore, one of the main challenges is to move toward common criteria that help reduce disparities in care between healthcare centers and autonomous communities, while respecting each person’s needs and circumstances.
“When it comes to rare diseases, ensuring continuity of care is just as important as making progress in diagnosis and access to treatments. Reaching adulthood should not mean a break in care or a loss of the knowledge accumulated about each patient. With FollowER, we want to help promote a planned and coordinated process that allows us to meet their needs at every stage of life,” says Clara Foyaca, a member of the AELMHU Board of Directors.
FollowER: A Proposal to Improve Continuity of Care
This project involves the development of a comprehensive document outlining a proposal for a holistic model of care transition, based on an analysis of the current situation and the identification of the primary needs of people with rare diseases. To this end, FollowER will establish a multidisciplinary Technical Committee and develop a working process that will include interviews with healthcare professionals, surveys, and expert meetings, with the aim of incorporating diverse perspectives and healthcare experiences into the development of the proposal.
The goal is to provide practical recommendations and guidance that can serve as a reference for healthcare professionals and help improve care for people with rare diseases throughout the National Health System.
“For people with rare diseases and their families, the transition from pediatric to adult care can be a source of great uncertainty. It’s not just about switching specialists, but about ensuring that the medical history of each patient is maintained and that their needs continue to be met. With FollowER, we want to help ensure that no one has to start from scratch when they reach adulthood,” says Mónica Rodríguez, secretary of the FEDER Board of Directors.
A project that brings together institutions, healthcare professionals, and patients
The initiative involves participation in the Ministry of Health’s Institutional Committee, alongside scientific societies and patient organizations, including: Spanish Association of Pediatrics (AEP), Platform of Patient Organizations (POP), Spanish Society for Healthcare Quality (SECA), Spanish Society of Healthcare Executives (SEDISA), Spanish Society of Hospital Pharmacy (SEFH), Spanish Society of Family and Community Medicine (semFYC), the Spanish Society of Internal Medicine (SEMI), the Spanish Society of Primary Care Physicians (SEMERGEN), and the Spanish Society of General and Family Physicians (SEMG).
This collaboration will make it possible to incorporate different clinical, care, and social perspectives in order to develop a well-founded proposal tailored to the realities of people with rare diseases.
